Progesterone and Kenalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Progesterone (progesterone) and Kenalog (triamcinolone acetonide). Common drug interactions include haemorrhage among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Progesterone and Kenalog. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Progesterone?

Progesterone has active ingredients of progesterone. It is often used in menopause. eHealthMe is studying from 21,021 Progesterone users. Check the latest studies of Progesterone.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

On Jul, 20, 2026

35 people who take Progesterone and Kenalog together, and have interactions are studied.

Progesterone and Kenalog drug interactions.

What are the common drug interactions of Progesterone and Kenalog, by gender? *:

female:

Haemorrhage (bleeding)
Hand fracture
Heart rate decreased
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Hyperhidrosis (abnormally increased sweating)
Immune system disorder
Fatigue (feeling of tiredness)
Accident at home
Foot fracture
Oropharyngeal pain

male:

Abdominal pain
Anion gap decreased
Lymphocyte count decreased
Monocyte count increased
Neutrophil percentage increased
Swelling
Toothache (tooth pain)
Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Cardiac failure congestive
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

What are the common drug interactions of Progesterone and Kenalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Injection site atrophy (injection site wasting or decreasing in size of a body organ, tissue, or part)

30-39:

Abscess (pus)
Alopecia (absence of hair from areas of the body)
Anxiety
Arthralgia (joint pain)
Back pain
Blood follicle stimulating hormone increased
Depression
Dizziness
Eye infection
Infection

40-49:

n/a

50-59:

Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
Ischaemic neuropathy (functional disturbance or pathological change in the peripheral nervous system due to inadequate supply of blood)
Mitral valve incompetence (inefficient heart valve)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pleural effusion (water on the lungs)
Renal failure acute (rapid kidney dysfunction)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Injection site atrophy (injection site wasting or decreasing in size of a body organ, tissue, or part)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Rash

60+:

Fatigue (feeling of tiredness)
Accident at home
Malaise (a feeling of general discomfort or uneasiness)
Osteochondrosis (a family of orthopaedic diseases of the joint that occur in children and adolescents)
Stress
Alveolar osteitis (complication of wound healing following extraction of a tooth)
Back injury
Cataract (clouding of the lens inside the eye)
Conjunctivitis (pink eye)
Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 17.14%
Primary Immunodeficiency Syndrome: 5 people, 14.29%
Immunodeficiency Common Variable: 5 people, 14.29%
Stress And Anxiety: 4 people, 11.43%
Asthma: 3 people, 8.57%
High Blood Pressure: 3 people, 8.57%
Sleep Disorder: 3 people, 8.57%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.57%
Muscle Spasms (muscle contraction): 3 people, 8.57%
High Blood Cholesterol: 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Progesterone and Kenalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously